IBM shares are trading at $238.99 during Monday's regular session, up +0.72% from Friday's close of $237.28, extending the stock's V-shaped recovery from its historic July collapse. The stock advanced despite trading ex-dividend today for a $1.69 quarterly payout, which normally exerts downward pressure — underscoring the strength of the current rebound bid.

Biogen (BIIB) delivered stronger recent performance with a significant Q2 2026 earnings beat and raised full-year guidance, while Pfizer (PFE) trades near 52-week lows ahead of its upcoming earnings. BIIB has posted robust year-to-date and one-year returns compared to PFE’s more modest gains, reflecting differing momentum in the biotechnology and pharmaceutical sectors.

AMGN trades near $385 with upcoming Q2 2026 earnings expected on August 4, following Q1 revenue growth of 6% to $8.6 billion and consistent earnings beats. BIIB closed recently around $203 after reporting Q2 revenue of $2.74 billion (up 3.4% year-over-year) and non-GAAP EPS well above estimates, with mixed stock reactions including gains of nearly 6% on one session.

AMGN and LLY both operate in the biopharmaceutical sector but differ markedly in scale and growth trajectories, with LLY demonstrating significantly higher recent revenue expansion driven by its GLP-1 portfolio. Recent market activity shows AMGN delivering steady single-digit revenue growth and maintaining consistent dividend payouts, while LLY reported 56% year-over-year revenue increase in the first quarter of 2026 alongside upward guidance revisions.

Both ETFs provide direct physical gold exposure by holding allocated gold bullion, tracking the LBMA Gold Price PM with minimal tracking error over time. Goldman Sachs Physical Gold ETF (AAAU) offers a significantly lower expense ratio of 0.18% compared to SPDR Gold Shares (GLD) at 0.40%, providing a structural cost advantage for long-term holders.

LRCX delivered approximately 82% year-to-date returns through early August 2026, significantly outpacing NVDA ’s roughly 20% gain over the same period. LRCX reported record quarterly revenue of $6.72 billion for the period ended June 28, 2026, with 30% year-over-year growth and gross margins reaching 52%.

MP is a leading U.S. rare earth producer with integrated mining and magnet manufacturing, benefiting from government price support and defense initiatives. UAMY focuses on antimony and related critical minerals, recently securing a major $245 million U.S. Defense Logistics Agency contract that has driven sharp revenue growth.

Both MP and USAR operate in the rare earth materials sector, positioning them as key players in U.S. efforts to reduce reliance on foreign supply chains for critical minerals used in electric vehicles, renewables, and defense applications. MP benefits from established production at its Mountain Pass facility, while USAR focuses on vertical integration including mining, processing, and magnet manufacturing with recent expansion moves.

COHR dropped -9.04% during Monday's regular trading session, surrendering a large portion of last week's explosive gains. The selloff is primarily profit-taking after the stock surged over +31% in the prior week, driven by FCC proposals to restrict Chinese optical transceiver imports and a $2 billion NVIDIA strategic partnership.

USA Rare Earth (USAR) shares edged approximately 3.9% higher over the last 30 days, trading near $19.20, reflecting a modest recovery from July lows. The company is aggressively executing a mine-to-magnet vertical integration strategy, anchored by its Stillwater, Oklahoma magnet manufacturing facility and multiple high-profile acquisitions.

TENX crashed -88.10% from its previous close of $13.44 to ~$1.60, with the collapse beginning in premarket trading and extending into the regular session. The primary catalyst: Tenax announced its Phase 3 LEVEL trial of TNX-103 (oral levosimendan) for PH-HFpEF failed to meet both its primary endpoint on 6-minute walk distance and its key secondary endpoint on symptom improvement.

LINC plunged -21.54% during Monday's regular session after reporting Q2 CY2026 earnings before the open, despite beating consensus on revenue ($142.6M vs. $138.9M) and EPS ($0.06 vs. -$0.01 expected). The primary selloff catalyst was student starts growing only +1% year-over-year, a dramatic deceleration from Q1's +19.5%, as fewer enrolled students attended first-day classes amid shifting decision-making patterns.

NABL plunged -35.27% to $3.23 during regular trading on Monday after reporting Q2 2026 results before the open, gapping down sharply from its Aug 7 close of $4.99. Q2 EPS of $0.10 matched consensus, but revenue of $138.2M narrowly missed the $138.38M estimate, while subscription revenue rose +6.1% year-over-year to $137.1M.

AEVA shares tumbled -11.65% during Monday's regular session, retreating to ~$23.52 from Friday's close of $26.62 as a sharp post-earnings profit-taking wave accelerated. The decline follows an explosive +51% rally over the prior week, triggered by better-than-feared Q2 results and the launch of an Optical Connectivity business targeting AI data center hyperscalers.

USAR is trading at $19.50 during Monday's regular session, up +0.88% from Friday's close of $19.33, adding to last week's +29% surge from $14.95. The primary catalyst is anticipation ahead of the company's Q2 2026 earnings release after today's market close, with analysts forecasting an EPS loss of -$0.19 on revenue of $6.45 million.

SION collapsed approximately -91.77% in pre-market trading Monday, plunging from Friday's close of $51.04 to around $4.20 during the regular session. The crash was triggered by the company's Q2 pipeline update, which revealed primary endpoint data for its cystic fibrosis program that fell dramatically short of investor expectations.

SkyWest (SKYW), a regional airline operator, reported Q2 2026 revenue growth of 7% year-over-year alongside share buybacks, supporting recent stock momentum with a 16.4% gain over the past month. United Airlines Holdings (UAL), a major network carrier, delivered Q2 2026 results that exceeded expectations, including adjusted diluted EPS of $1.99, and raised full-year 2026 adjusted EPS guidance despite higher fuel costs.

PureCycle Technologies shares closed at $7.21 on August 7, 2026, reflecting a modest decline of approximately 1.2% over the trailing 30-day period, while the stock has lost roughly 20% year-to-date. The company reported Q2 2026 revenue of $4.51 million — a 173% year-over-year increase and its sixth consecutive quarter of sequential revenue growth — but missed consensus estimates and posted a net loss of $142.2 million.

Nextracker (Nasdaq: NXT) shares traded near $103.26 in early August 2026, reflecting a roughly 6% decline over the preceding 30 days and a more pronounced retreat from the 52-week high of $163.13. The company delivered record fiscal 2026 revenue of $3.56 billion, up 20% year-over-year, and raised its fiscal 2027 revenue guidance to a range of $3.8 billion to $4.1 billion.

DigitalOcean shares have pulled back roughly 5% over the past 30 days, trading near $124 after a volatile quarter that saw the stock swing from above $180 in early June to current levels. Second-quarter 2026 results exceeded consensus estimates on both revenue ($281.2 million, up 28.6% year-over-year) and non-GAAP EPS ($0.45 vs. $0.26 expected), yet the stock dropped sharply immediately following the report.